A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0 | - | - | 2.8M | - |
| Net Income | -5.7M | -5.7M | -5.3M | -3.1M | -3.9M |
| EPS | $-0.10 | $-0.10 | $-0.11 | $-0.16 | $-0.24 |
| Free Cash Flow | -2.3M | -2.3M | -5.4M | -2.6M | -2.3M |
| ROIC | -39.7% | -23.2% | -55.4% | -112.8% | -37.2% |
| Gross Margin | - | - | - | 39.6% | - |
| Debt/Equity | 0.00 | 0.47 | 0.33 | - | 2.82 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -4.9M | -4.9M | -6.2M | -4.3M | -3.0M |
| Operating Margin | 0.0% | - | - | -152.0% | - |
| ROE | -52.2% | -45.0% | -82.9% | -1160.8% | -181.2% |
| Shares Outstanding | 57M | 57M | 47M | 20M | 17M |
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | N/A | 2.8M | N/A | N/A | 0 |
| Gross Margin | N/A | 39.6% | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -3.0M | -4.3M | -6.2M | -4.9M | -4.9M |
| Op. Margin | N/A | -152.0% | N/A | N/A | 0.0% |
| Net Income | -3.9M | -3.1M | -5.3M | -5.7M | -5.7M |
| Net Margin | N/A | -109.5% | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -37.2% | -112.8% | -55.4% | -23.2% | -39.7% |
| ROE | -181.2% | -1160.8% | -82.9% | -45.0% | -52.2% |
| ROA | -42.0% | -34.6% | -34.4% | -24.6% | -23.8% |
| Cash Flow | |||||
| Op. Cash Flow | -2.3M | -2.6M | -5.4M | -2.3M | -2.3M |
| Free Cash Flow | -2.3M | -2.6M | -5.4M | -2.3M | -2.3M |
| Owner Earnings | -2.6M | -3.0M | -6.5M | -3.6M | -3.6M |
| CapEx | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 338K | 403K | 1.1M | 1.3M | 1.3M |
| Growth CapEx | N/A | N/A | N/A | N/A | 0 |
| D&A | 338K | 403K | 1.1M | 1.3M | 1.3M |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | 4.1M | 1.2M | 3.4M | 3.9M | -1.3M |
| Cash & Equiv. | 2.0M | 333K | 1.4M | 1.3M | 1.3M |
| Long-Term Debt | N/A | N/A | 99K | 4.7M | 4.7M |
| Debt/Equity | 2.82 | N/A | 0.33 | 0.47 | 0.00 |
| Interest Coverage | -2.2 | -6.7 | -5.5 | -3.1 | -3.1 |
| Equity | 2.2M | -1.6M | 14M | 11M | 11M |
| Total Assets | 9.4M | 8.4M | 23M | 24M | 24M |
| Total Liabilities | 7.2M | N/A | 8.1M | 13M | 13M |
| Intangibles | N/A | N/A | 8.7M | 12M | 12M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A |
| Working Capital | 2.1M | -6.7M | -4.5M | -3.2M | -3.2M |
| Current Assets | 3.2M | 1.8M | 3.0M | 2.6M | 2.6M |
| Current Liabilities | 1.1M | 8.4M | 7.6M | 5.8M | 5.8M |
| Per Share Data | |||||
| EPS | -0.24 | -0.16 | -0.11 | -0.10 | -0.10 |
| Owner EPS | -0.16 | -0.15 | -0.14 | -0.06 | -0.06 |
| Book Value | 0.13 | -0.08 | 0.31 | 0.19 | 0.19 |
| Cash Flow/Share | -0.14 | -0.13 | -0.11 | -0.04 | -0.08 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 16.6M | 19.6M | 47.0M | 57.5M | 57.5M |
| Valuation | |||||
| P/E Ratio | -61.0 | -123.4 | -28.4 | -4.6 | -10.8 |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 110.5 | N/A | 10.4 | 2.4 | 5.6 |
| Price/Sales | N/A | 135.1 | N/A | N/A | N/A |
| FCF Yield | -1.0% | -0.7% | -3.6% | -8.8% | -3.8% |
| Market Cap | 240M | 378M | 151M | 26M | 62M |
| Avg. Price | 13.31 | 24.22 | 7.85 | 1.50 | 1.08 |
| Year-End Price | 14.45 | 19.26 | 3.21 | 0.46 | 1.08 |
OBSERVE MEDICAL passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 39.6%.
OBSERVE MEDICAL (OBSRV-OL) has a 5-year average return on invested capital (ROIC) of -57.1%. This is below average and may indicate limited pricing power.
OBSERVE MEDICAL (OBSRV-OL) has a market capitalization of $62M. It is classified as a small-cap stock.
OBSERVE MEDICAL (OBSRV-OL) does not currently pay a regular dividend.
OBSERVE MEDICAL (OBSRV-OL) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
OBSERVE MEDICAL (OBSRV-OL) has a debt-to-equity ratio of 0.47. This indicates a conservatively financed balance sheet.
OBSERVE MEDICAL (OBSRV-OL) reported earnings per share (EPS) of $-0.10 in its most recent fiscal year.
OBSERVE MEDICAL (OBSRV-OL) has a return on equity (ROE) of -45.0%. A negative ROE may indicate losses or negative equity.
OBSERVE MEDICAL (OBSRV-OL) has a 5-year average gross margin of 39.6%. This indicates decent pricing power.
The Ledger Terminal provides 4 years of financial data for OBSERVE MEDICAL (OBSRV-OL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
OBSERVE MEDICAL (OBSRV-OL) has a book value per share of $0.19, based on its most recent annual SEC filing.